WAO Email News and Notes

Richard F. Lockey Dear Colleagues:

Four months ago, I was honored to assume the Presidency of the World Allergy Organization (WAO). Since then, the WAO Board and staff have continued diligently to carry forward a variety of different projects, the most important of which in the immediate future is the Post-graduate International Scientific Conference: "Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care" to be held in Dubai, 5-8 December, 2010.

Please join us at the WAO International Scientific Conference (WISC) 2010 in Dubai, December 5-8.
This post-graduate conference will feature approximately 50 renowned faculty members, who will update attendees on the co-morbid conditions associated with asthma, including: vocal cord dysfunction, rhinosinusitis, eczema, bronchiectasis, gastroesophageal reflux disease, obesity, chronic obstructive pulmonary disease, osteoporosis, and endocrine abnormalities. These and many other co-morbid conditions of asthma will be reviewed and discussed. A few of the many other subjects to be covered include Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), appropriate immunizations for asthma and COPD, rhinoscopy, bone scans, and the diagnosis and treatment of sleep apnea, a common co-morbid condition of asthma. For more information about this International Scientific Conference please visit www.worldallergy.org/2010Dubai/.

WAO Board Retreat
The entire WAO Board will meet in London at the annual meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in early June. Board members have assembled into ten task forces, formed from three-strategic focus areas, and will report their progress during a "retreat" prior to the Board meeting.

The Fiscal task forces are working on fundraising and other financial matters. Content is another strategic area of focus, and the task forces are discussing clinical immunology and primary immunodeficiency, as well as pediatric allergy, asthma and immunology, and how these should be better integrated into the repertoire of subjects covered at the World Allergy Congress (WAC) and in other educational endeavors. The third strategic focus is Programmatic/WAO Activities, and those task forces are working on ways to grow the WAO Journal, and WAO website, as well as how to better integrate junior members into WAO activities.

In summary, this has been an exciting four months for me. I am pleased that so many of you have taken the time to write me and to express interest in various projects and activities. I appreciate the wonderful cooperation and assistance of the WAO Board and its staff. Keep those emails coming to: rlockey@health.usf.edu

With warm regards,

Richard F. Lockey, M.D.
President, World Allergy Organization

Volume 7, Issue 5 May 2010
Dear Colleagues: Four months ago, I was honored to assume the Presidency of the World Allergy Organization (WAO). Since then, the WAO Board and staff have continued diligently to carry forward a variety of different projects, the most important of which in the immediate future is the Post-graduate International Scientific Conference: "Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care" to be held in Dubai, 5-8 December, 2010. Please join us at the WAO International Scientific Conference (WISC) 2010 in Dubai, December 5-8. This post-graduate conference will feature approximately 50 renowned faculty members, who will update attendees on the co-morbid conditions associated with asthma, including: vocal cord dysfunction, rhinosinusitis, eczema, bronchiectasis, gastroesophageal reflux disease, obesity, chronic obstructive pulmonary disease, osteoporosis, and endocrine abnormalities. These and many other co-morbid conditions of asthma will be reviewed and discussed. A few of the many other subjects to be covered include Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), appropriate immunizations for asthma and COPD, rhinoscopy, bone scans, and the diagnosis and treatment of sleep apnea, a common co-morbid condition of asthma. For more information about this International Scientific Conference please visit www.worldallergy.org/2010Dubai/. WAO Board Retreat The entire WAO Board will meet in London at the annual meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in early June. Board members have assembled into ten task forces, formed from three-strategic focus areas, and will report their progress during a "retreat" prior to the Board meeting. The Fiscal task forces are working on fundraising and other financial matters. Content is another strategic area of focus, and the task forces are discussing clinical immunology and primary immunodeficiency, as well as pediatric allergy, asthma and immunology, and how these should be better integrated into the repertoire of subjects covered at the World Allergy Congress (WAC) and in other educational endeavors. The third strategic focus is Programmatic/WAO Activities, and those task forces are working on ways to grow the WAO Journal, and WAO website, as well as how to better integrate junior members into WAO activities. In summary, this has been an exciting four months for me. I am pleased that so many of you have taken the time to write me and to express interest in various projects and activities. I appreciate the wonderful cooperation and assistance of the WAO Board and its staff. Keep those emails coming to: rlockey@health.usf.edu With warm regards, Richard F. Lockey, M.D. President, World Allergy Organization